Outcomes of triple-negative breast cancer (TNBC) versus non-TNBC patients: Does the survival vary for all stages?

被引：0
|
作者：
Agarwal, Gaurav
Nanda, Gitika
Lal, Punita
Agrawal, Sushma
Krishnani, Narendra
Kumari, Niraj
Chand, Gyan
Mishra, Anjali
Agarwal, Amit
Verma, Ashok Kumar
Mishra, Saroj Kanta
机构：
[1] SGPGIMS, Dept Endocrine & Breast Surg, Lucknow, Uttar Pradesh, India
[2] SGPGIMS Lucknow, Lucknow, Uttar Pradesh, India
[3] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India
[4] SGPGIMS, Pathol, Lucknow, Uttar Pradesh, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e12034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12034
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic effect of beta blockers (BB) in triple-negative breast cancer (TNBC) patients
    Munzone, Elisabetta
    Botteri, Edoardo
    Rotmensz, Nicole
    Cipolla, Carlo Maria
    Zanelotti, Arnaldo
    Adamoli, Laura
    Viale, Giuseppe
    Goldhirsch, Aron
    Gandini, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Does triple-negative breast cancer (TNBC) have distinct clinicopathologic characteristics and prognostic significance?
    Rhee, J.
    Oh, S.
    Oh, D.
    Im, S.
    Lee, S.
    Kim, D.
    Heo, D.
    Park, I.
    Bang, Y.
    Kim, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [33] Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples
    Campone, Mario
    Valo, Isabelle
    Jezequel, Pascal
    Moreau, Marie
    Boissard, Alice
    Campion, Loic
    Loussouarn, Delphine
    Verriele, Veronique
    Coqueret, Olivier
    Guette, Catherine
    MOLECULAR & CELLULAR PROTEOMICS, 2015, 14 (11) : 2936 - 2946
  • [34] BIOMARKER IDENTIFICATION IN TRIPLE NEGATIVE BREAST CANCER (TNBC) PATIENTS
    Mohan, Kabhilan
    Shih, Andrew
    Liew, Anthony
    Khalili, Houman
    Sultan, Gwyneth
    Shapira, Iuliana
    Lee, Annette
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (04) : 920 - 920
  • [35] Analysis of the JAK2 gene in triple-negative breast cancer (TNBC)
    Stanek, L.
    Tesarova, P.
    Vocka, M.
    Petruzelka, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] Prognostic role of stem cell markers in triple-negative breast cancer (TNBC)
    Song, J.
    Apple, S.
    Goodglick, L.
    Mah, V. H.
    Kim, S. R.
    Alavi, M. T.
    Chia, D.
    Deng, X.
    Chang, H. R.
    CANCER RESEARCH, 2013, 73
  • [37] Adjuvant chemotherapy in small node-negative triple-negative breast cancer (TNBC).
    Steenbruggen, Tessa Gerjanne
    Van Ramshorst, Mette S.
    van Werkhoven, Erik
    Dezentje, Vincent O.
    Siesling, Sabine
    Linn, Sabine C.
    Sonke, Gabe S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Minghui Zhang
    Xiaosan Zhang
    Shu Zhao
    Yan Wang
    Wenyu Di
    Gangling Zhao
    Maopeng Yang
    Qingyuan Zhang
    Targeted Oncology, 2014, 9 : 349 - 357
  • [39] PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)
    Ghosh, Joydeep
    Chatterjee, Meheli
    Ganguly, Sandip
    Datta, Anuparva
    Biswas, Bivas
    Mukherjee, Geetashree
    Agarwal, Sanjit
    Ahmed, Rosina
    Chatterjee, Sanjoy
    Dabkara, Deepak
    ECANCERMEDICALSCIENCE, 2021, 15
  • [40] Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
    Hoadley, Katherine A.
    Powell, Bradford C.
    Kanavy, Dona
    Marron, David
    Mose, Lisle E.
    Hyslop, Terry
    Berry, Donald A.
    Hahn, Olwen
    Tolaney, Sara M.
    Sikov, William M.
    Perou, Charles M.
    Carey, Lisa A.
    CANCER RESEARCH, 2020, 80 (04)
12345